Senate Health Committee Ranking Member Cassidy Rebukes Biden Admin Attempt to Dramatically Increase FDA Authority Over Laboratory Developed Tests
April 30, 2024
April 30, 2024
WASHINGTON, April 30 -- Sen. Bill Cassidy, R-Louisiana, ranking member of the Senate Health, Education, Labor and Pensions Committee, issued the following statement on April 29, 2024:
* * *
Today, U.S. Senator Bill Cassidy, M.D. (R-LA), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a statement on the Food and Drug Administration's (FDA) final rule to classify Laboratory Developed Tests (LDTs) as medical devices under the . . .
* * *
Today, U.S. Senator Bill Cassidy, M.D. (R-LA), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a statement on the Food and Drug Administration's (FDA) final rule to classify Laboratory Developed Tests (LDTs) as medical devices under the . . .